位置:首页 > 蛋白库 > SRCN1_HUMAN
SRCN1_HUMAN
ID   SRCN1_HUMAN             Reviewed;        1183 AA.
AC   Q9C0H9; Q75T46; Q8N4W8;
DT   16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 4.
DT   03-AUG-2022, entry version 171.
DE   RecName: Full=SRC kinase signaling inhibitor 1 {ECO:0000305};
DE   AltName: Full=SNAP-25-interacting protein;
DE            Short=SNIP {ECO:0000303|PubMed:19146815};
DE   AltName: Full=p130Cas-associated protein;
DE   AltName: Full=p140Cap;
GN   Name=SRCIN1 {ECO:0000312|HGNC:HGNC:29506};
GN   Synonyms=KIAA1684, P140 {ECO:0000303|PubMed:19146815},
GN   SNIP {ECO:0000303|PubMed:19146815};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:BAB21775.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Sugiyama A., Inoue H., Oka M.;
RT   "Homo sapiens cDNA, SNIP homolog.";
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 422-1183 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [6] {ECO:0000305}
RP   PROTEIN SEQUENCE OF 434-453; 620-647; 711-721; 739-745; 828-847; 969-995;
RP   1012-1023; 1085-1100; 1111-1128 AND 1134-1145 (ISOFORM 1), FUNCTION,
RP   SUBCELLULAR LOCATION, INTERACTION WITH BCAR1, AND PHOSPHORYLATION.
RX   PubMed=14657239; DOI=10.1091/mbc.e03-09-0689;
RA   Di Stefano P., Cabodi S., Erba E.B., Margaria V., Bergatto E.,
RA   Giuffrida M.G., Silengo L., Tarone G., Turco E., Defilippi P.;
RT   "p130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated
RT   protein involved in cell spreading.";
RL   Mol. Biol. Cell 15:787-800(2004).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH CSK AND SRC.
RX   PubMed=17525734; DOI=10.1038/sj.emboj.7601724;
RA   Di Stefano P., Damiano L., Cabodi S., Aramu S., Tordella L., Praduroux A.,
RA   Piva R., Cavallo F., Forni G., Silengo L., Tarone G., Turco E.,
RA   Defilippi P.;
RT   "p140Cap protein suppresses tumour cell properties, regulating Csk and Src
RT   kinase activity.";
RL   EMBO J. 26:2843-2855(2007).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=18475297; DOI=10.1038/sj.bjc.6604365;
RA   Kennedy S., Clynes M., Doolan P., Mehta J.P., Rani S., Crown J.,
RA   O'Driscoll L.;
RT   "SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in
RT   breast cancer and is not expressed in normal breast tissue.";
RL   Br. J. Cancer 98:1641-1645(2008).
RN   [9]
RP   INTERACTION WITH SORBS3 AND SYP.
RX   PubMed=18662323; DOI=10.1111/j.1471-4159.2008.05585.x;
RA   Ito H., Atsuzawa K., Sudo K., Di Stefano P., Iwamoto I., Morishita R.,
RA   Takei S., Semba R., Defilippi P., Asano T., Usuda N., Nagata K.;
RT   "Characterization of a multidomain adaptor protein, p140Cap, as part of a
RT   pre-synaptic complex.";
RL   J. Neurochem. 107:61-72(2008).
RN   [10]
RP   FUNCTION, INTERACTION WITH CTTN AND MAPRE3, AND SUBCELLULAR LOCATION.
RX   PubMed=19146815; DOI=10.1016/j.neuron.2008.11.013;
RA   Jaworski J., Kapitein L.C., Gouveia S.M., Dortland B.R., Wulf P.S.,
RA   Grigoriev I., Camera P., Spangler S.A., Di Stefano P., Demmers J.,
RA   Krugers H., Defilippi P., Akhmanova A., Hoogenraad C.C.;
RT   "Dynamic microtubules regulate dendritic spine morphology and synaptic
RT   plasticity.";
RL   Neuron 61:85-100(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; THR-52; SER-53; SER-64;
RP   SER-364; SER-857; SER-866 AND THR-884, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Acts as a negative regulator of SRC by activating CSK which
CC       inhibits SRC activity and downstream signaling, leading to impaired
CC       cell spreading and migration. Regulates dendritic spine morphology.
CC       Involved in calcium-dependent exocytosis. May play a role in
CC       neurotransmitter release or synapse maintenance.
CC       {ECO:0000269|PubMed:14657239, ECO:0000269|PubMed:17525734,
CC       ECO:0000269|PubMed:19146815}.
CC   -!- SUBUNIT: Interacts with the N-terminal coiled-coil region of SNAP25 (By
CC       similarity). Interacts with BCAR1/p130Cas and SRC through its C-
CC       terminal domain. Interacts with CSK, CTTN, SORBS3/vinexin, SYP and
CC       MAPRE3/EB3. {ECO:0000250, ECO:0000269|PubMed:14657239,
CC       ECO:0000269|PubMed:17525734, ECO:0000269|PubMed:18662323,
CC       ECO:0000269|PubMed:19146815}.
CC   -!- INTERACTION:
CC       Q9C0H9; P56945: BCAR1; NbExp=3; IntAct=EBI-1393949, EBI-702093;
CC       Q9C0H9; P12931: SRC; NbExp=3; IntAct=EBI-1393949, EBI-621482;
CC       Q9C0H9-4; Q99732: LITAF; NbExp=3; IntAct=EBI-25907611, EBI-725647;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9QXY2}.
CC       Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q9QXY2}. Cell
CC       projection, axon {ECO:0000250|UniProtKB:Q9QXY2}. Cell projection,
CC       dendrite {ECO:0000250|UniProtKB:Q9QXY2}. Presynapse
CC       {ECO:0000250|UniProtKB:Q9QXY2}. Postsynapse
CC       {ECO:0000250|UniProtKB:Q9QXY2}. Postsynaptic density
CC       {ECO:0000250|UniProtKB:Q9QXY2}. Note=Localized to the perinuclear
CC       region, lamellopodia, cortical actin and actin stress fibers but not to
CC       focal adhesions. Strongly expressed in axons and dendrites of the CA1
CC       and CA3 hippocampal regions and of the dentate gyrus. Detected in both
CC       presynapses and postsynapses and enriched in postsynaptic density
CC       fractions. {ECO:0000250|UniProtKB:Q9QXY2}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9C0H9-5; Sequence=Displayed;
CC       Name=2 {ECO:0000305};
CC         IsoId=Q9C0H9-2; Sequence=VSP_059451, VSP_059454;
CC       Name=3;
CC         IsoId=Q9C0H9-4; Sequence=VSP_059450, VSP_059452, VSP_059453;
CC   -!- TISSUE SPECIFICITY: Expressed in some primary breast carcinomas where
CC       its presence is significantly associated with increased tumor size. Not
CC       detected in normal breast tissue. {ECO:0000269|PubMed:18475297}.
CC   -!- PTM: Tyrosine-phosphorylated in response to EGF and to cell adhesion to
CC       integrin ligands. {ECO:0000269|PubMed:14657239}.
CC   -!- SIMILARITY: Belongs to the SRCIN1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB127405; BAD03968.1; -; mRNA.
DR   EMBL; AK126665; BAC86634.1; -; mRNA.
DR   EMBL; AC006449; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC115090; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC129916; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC244153; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877653; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033233; AAH33233.1; -; mRNA.
DR   EMBL; AB051471; BAB21775.1; -; mRNA.
DR   CCDS; CCDS45660.1; -. [Q9C0H9-5]
DR   RefSeq; NP_079524.2; NM_025248.2. [Q9C0H9-5]
DR   AlphaFoldDB; Q9C0H9; -.
DR   SMR; Q9C0H9; -.
DR   BioGRID; 123275; 22.
DR   ELM; Q9C0H9; -.
DR   IntAct; Q9C0H9; 8.
DR   MINT; Q9C0H9; -.
DR   STRING; 9606.ENSP00000484715; -.
DR   BindingDB; Q9C0H9; -.
DR   ChEMBL; CHEMBL2150836; -.
DR   GlyGen; Q9C0H9; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9C0H9; -.
DR   PhosphoSitePlus; Q9C0H9; -.
DR   BioMuta; SRCIN1; -.
DR   DMDM; 296452948; -.
DR   EPD; Q9C0H9; -.
DR   jPOST; Q9C0H9; -.
DR   MassIVE; Q9C0H9; -.
DR   MaxQB; Q9C0H9; -.
DR   PaxDb; Q9C0H9; -.
DR   PeptideAtlas; Q9C0H9; -.
DR   PRIDE; Q9C0H9; -.
DR   ProteomicsDB; 80047; -. [Q9C0H9-2]
DR   ProteomicsDB; 80048; -. [Q9C0H9-4]
DR   ProteomicsDB; 80049; -. [Q9C0H9-5]
DR   Antibodypedia; 74250; 74 antibodies from 21 providers.
DR   DNASU; 80725; -.
DR   Ensembl; ENST00000615049.4; ENSP00000480869.1; ENSG00000273608.4. [Q9C0H9-5]
DR   Ensembl; ENST00000617146.5; ENSP00000484715.1; ENSG00000277363.5. [Q9C0H9-5]
DR   GeneID; 80725; -.
DR   KEGG; hsa:80725; -.
DR   MANE-Select; ENST00000617146.5; ENSP00000484715.1; NM_025248.3; NP_079524.2.
DR   CTD; 80725; -.
DR   DisGeNET; 80725; -.
DR   GeneCards; SRCIN1; -.
DR   HGNC; HGNC:29506; SRCIN1.
DR   HPA; ENSG00000277363; Tissue enriched (brain).
DR   MIM; 610786; gene.
DR   neXtProt; NX_Q9C0H9; -.
DR   OpenTargets; ENSG00000277363; -.
DR   PharmGKB; PA165432823; -.
DR   VEuPathDB; HostDB:ENSG00000277363; -.
DR   eggNOG; ENOG502QPNH; Eukaryota.
DR   GeneTree; ENSGT00940000157961; -.
DR   InParanoid; Q9C0H9; -.
DR   OMA; FRMAPSS; -.
DR   OrthoDB; 65773at2759; -.
DR   PhylomeDB; Q9C0H9; -.
DR   TreeFam; TF332255; -.
DR   PathwayCommons; Q9C0H9; -.
DR   SignaLink; Q9C0H9; -.
DR   SIGNOR; Q9C0H9; -.
DR   BioGRID-ORCS; 80725; 19 hits in 1065 CRISPR screens.
DR   ChiTaRS; SRCIN1; human.
DR   GenomeRNAi; 80725; -.
DR   Pharos; Q9C0H9; Tbio.
DR   PRO; PR:Q9C0H9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9C0H9; protein.
DR   Bgee; ENSG00000277363; Expressed in C1 segment of cervical spinal cord and 93 other tissues.
DR   ExpressionAtlas; Q9C0H9; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:MGI.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IEA:Ensembl.
DR   GO; GO:0030027; C:lamellipodium; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0098793; C:presynapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0050709; P:negative regulation of protein secretion; IEA:Ensembl.
DR   GO; GO:0061099; P:negative regulation of protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0061001; P:regulation of dendritic spine morphogenesis; IMP:UniProtKB.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB.
DR   InterPro; IPR022782; AIP3-like_C.
DR   InterPro; IPR026727; Srcin1.
DR   PANTHER; PTHR22741:SF5; PTHR22741:SF5; 1.
DR   Pfam; PF03915; AIP3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Exocytosis; Methylation;
KW   Phosphoprotein; Reference proteome; Synapse.
FT   CHAIN           1..1183
FT                   /note="SRC kinase signaling inhibitor 1"
FT                   /id="PRO_0000072011"
FT   REGION          1..44
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          284..379
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          466..643
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          647..697
FT                   /note="Interaction with SNAP25"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXY2"
FT   REGION          861..907
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          949..1032
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1058..1081
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1105..1183
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          654..674
FT                   /evidence="ECO:0000255"
FT   COILED          726..746
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        288..302
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        482..498
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        500..536
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        598..623
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        981..996
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        999..1013
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1014..1029
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1132..1183
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         45
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         52
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         53
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         64
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         165
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXY2"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXY2"
FT   MOD_RES         179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         241
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         324
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         329
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         336
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         364
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         396
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         493
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         496
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         500
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         501
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         503
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         513
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         515
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         517
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         522
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         598
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         621
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         624
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         637
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         844
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         857
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         866
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         884
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         987
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         1043
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   MOD_RES         1060
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QWI6"
FT   VAR_SEQ         1..694
FT                   /note="Missing (in isoform 3)"
FT                   /id="VSP_059450"
FT   VAR_SEQ         1..180
FT                   /note="MGNAPSQDPERSSPPMLSADDAEYPREYRTLGGGGGGGSGGRRFSNVGLVHT
FT                   SERRHTVIAAQSLEALSGLQKADADRKRDAFMDHLKSKYPQHALALRGQQDRMREQPNY
FT                   WSFKTRSSRHTQGAQPGLADQAAKLSYASAESLETMSEAELPLGFSRMNRFRQSLPLSR
FT                   SASQTKLRSP -> MRGAWVHLHSGAASSLRPCRCGAGAAPKSSPRSPGGRRGDGSSDS
FT                   EGGVSFA (in isoform 2)"
FT                   /id="VSP_059451"
FT   VAR_SEQ         910..951
FT                   /note="AAERDWEEKRAALTQYSAKDINRLLEETQAELLKAIPDLDCA -> VLGPGI
FT                   VGGAMSQVHTFLRPSFLEWGVPILWVFFLGGGGPVP (in isoform 3)"
FT                   /id="VSP_059452"
FT   VAR_SEQ         952..1183
FT                   /note="Missing (in isoform 3)"
FT                   /id="VSP_059453"
FT   VAR_SEQ         1141..1183
FT                   /note="Missing (in isoform 2)"
FT                   /id="VSP_059454"
FT   CONFLICT        177
FT                   /note="L -> P (in Ref. 1; BAD03968)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        442
FT                   /note="Missing (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        609
FT                   /note="T -> I (in Ref. 2; BAC86634)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        720
FT                   /note="L -> I (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        833
FT                   /note="V -> M (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        841..842
FT                   /note="LS -> IN (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        971
FT                   /note="H -> E (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        978
FT                   /note="R -> K (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        995
FT                   /note="Y -> R (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1086
FT                   /note="I -> L (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1115
FT                   /note="Q -> P (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1122
FT                   /note="S -> G (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1140
FT                   /note="A -> V (in Ref. 2; BAC86634)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1183 AA;  127105 MW;  52BF566E715EF6FF CRC64;
     MGNAPSQDPE RSSPPMLSAD DAEYPREYRT LGGGGGGGSG GRRFSNVGLV HTSERRHTVI
     AAQSLEALSG LQKADADRKR DAFMDHLKSK YPQHALALRG QQDRMREQPN YWSFKTRSSR
     HTQGAQPGLA DQAAKLSYAS AESLETMSEA ELPLGFSRMN RFRQSLPLSR SASQTKLRSP
     GVLFLQFGEE TRRVHITHEV SSLDTLHALI AHMFPQKLTM GMLKSPNTAI LIKDEARNVF
     YELEDVRDIQ DRSIIKIYRK EPLYAAFPGS HLTNGDLRRE MVYASRESSP TRRLNNLSPA
     PHLASGSPPP GLPSGLPSGL QSGSPSRSRL SYAGGRPPSY AGSPVHHAAE RLGGAPAAQG
     VSPSPSAILE RRDVKPDEDL ASKAGGMVLV KGEGLYADPY GLLHEGRLSL AAAAGDPFAY
     PGAGGLYKRG SVRSLSTYSA AALQSDLEDS LYKAAGGGGP LYGDGYGFRL PPSSPQKLAD
     VAAPPGGPPP PHSPYSGPPS RGSPVRQSFR KDSGSSSVFA ESPGGKTRSA GSASTAGAPP
     SELFPGPGER SLVGFGPPVP AKDTETRERM EAMEKQIASL TGLVQSALLR GSEPETPSEK
     IEGSNGAATP SAPCGSGGRS SGATPVSGPP PPSASSTPAG QPTAVSRLQM QLHLRGLQNS
     ASDLRGQLQQ LRKLQLQNQE SVRALLKRTE AELSMRVSEA ARRQEDPLQR QRTLVEEERL
     RYLNDEELIT QQLNDLEKSV EKIQRDVSHN HRLVPGPELE EKALVLKQLG ETLTELKAHF
     PGLQSKMRVV LRVEVEAVKF LKEEPQRLDG LLKRCRGVTD TLAQIRRQVD EGVWPPPNNL
     LSQSPKKVTA ETDFNKSVDF EMPPPSPPLN LHELSGPAEG ASLTPKGGNP TKGLDTPGKR
     SVDKAVSVEA AERDWEEKRA ALTQYSAKDI NRLLEETQAE LLKAIPDLDC ASKAHPGPAP
     TPDHKPPKAP HGQKAAPRTE PSGRRGSDEL TVPRYRTEKP SKSPPPPPPR RSFPSSHGLT
     TTRTGEVVVT SKKDSAFIKK AESEELEVQK PQVKLRRAVS EVARPASTPP IMASAIKDED
     DEDRIIAELE SGGGSVPPMK VVTPGASRLK AAQGQAGSPD KSKHGKQRAE YMRIQAQQQA
     TKPSKEMSGS NETSSPVSEK PSASRTSIPV LTSFGARNSS ISF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024